---
title: "Abcellera Biologics (ABCL.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ABCL.US/norm.md"
symbol: "ABCL.US"
name: "Abcellera Biologics"
parent: "https://longbridge.com/en/quote/ABCL.US.md"
datetime: "2026-05-20T02:32:00.836Z"
locales:
  - [en](https://longbridge.com/en/quote/ABCL.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ABCL.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ABCL.US/norm.md)
---

# Abcellera Biologics (ABCL.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1424 | -0.0304 | -0.1911 | -0.1200 | -0.1532 |
| ROE | -18.13% | -3.71% | -23.18% | -13.68% | -17.55% |
| Revenue | 8.31M | 44.85M | 8.96M | 17.08M | 4.24M |
| Net income | -43.16M | -8.95M | -57.12M | -34.73M | -45.62M |
| Operating income | -57.52M | -28.58M | -76.28M | -49.59M | -62.66M |
| Gross margin | 100.00% | -11.68% | -514.49% | -129.53% | -903.45% |
| Net margin | -519.12% | -19.94% | -637.84% | -203.27% | -1077.24% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.31B | 1.36B | 1.36B | 1.40B | 1.34B |
| Leverage | 1.39 | 1.40 | 1.41 | 1.39 | 1.31 |
| BVPS | 3.09 | 3.22 | 3.22 | 3.41 | 3.43 |
| Turnover | 0.0597 | 0.0553 | 0.0257 | 0.0234 | 0.0165 |
| Cash & STI | 504.73M | 533.83M | 495.67M | 553.08M | 605.27M |
| Inv & Rec | - | 6.34M | - | - | - |
| LT assets | 422.81M | 428.00M | 427.36M | 424.02M | 347.10M |
| Net debt | -370.42M | -390.61M | -353.45M | -411.00M | -537.42M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -33.52M | -34.74M | -52.59M | -32.40M | -11.55M |
| Investing CF | -25.08M | 75.14M | 36.49M | -31.81M | 7.93M |
| Financing CF | 7.19M | 4.12M | 7.37M | -3.38M | 5.97M |
| Free CF | -7.78M | -6.97M | -44.36M | -61.07M | -63.60M |
| OCF coverage | -875.05% | -352.97% | -589.09% | -242.45% | -108.63% |
| Repaid & issued | 7.19M | 10.52M | 7.55M | 5.50M | 6.15M |
| CapEx | -3.83M | -9.84M | -8.93M | -13.37M | -10.64M |